A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK. [PDF]
Beillat, Maud +4 more
core +1 more source
Post-marketing Surveillance of a Live Attenuated Herpes Zoster Vaccine (SKYZoster<sup>®</sup>) in Adults Aged ≥50 Years in Korea. [PDF]
Baik SH, Lee H, Kim H, Kim HY.
europepmc +1 more source
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults. [PDF]
Wessely A +6 more
europepmc +1 more source
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations. [PDF]
Marra F, Yip M, Cragg JJ, Vadlamudi NK.
europepmc +1 more source
Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China. [PDF]
Sun X +10 more
europepmc +1 more source
Annual incidence rates of herpes zoster among an immunocompetent population in the United States [PDF]
core +1 more source
Effect of herpes zoster vaccine on patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis. [PDF]
Jiao X, Zhu J, Ding Y, Xiao M, Zhai Z.
europepmc +1 more source
Comment on Limitations of "Assessing Herpes Zoster Vaccine Efficacy in Patients With Diabetes: A Community-Based Cohort Study". [PDF]
Cohen RA, Yun H, Williams C.
europepmc +1 more source
Coalition of advocates to vaccinate of Western European citizens aged 60 years and older [PDF]
Chidiac, Christian +8 more
core
Evaluating the impact of the vaccination prescription program on herpes zoster vaccine coverage in Ningbo, China: An interrupted time series analysis. [PDF]
Wang J +5 more
europepmc +1 more source

